Indian court finds for Cipla against Roche; Sanofi looking for partners in India;

 @FiercePharma: GSK's Benlysta gets another shot at U.K. market. Story | Follow @FiercePharma

>  Cipla says that an Indian court has ruled against Roche, which claimed that the Indian drugmaker's Erlocip, doesn't infringe on Roche's cancer treatment Tarceva. Story 

> Teva Pharmaceutical Industries ($TEVA) has filed suit against Perrigo ($PRGO) over saying it is stepping on its patents for the ProAir asthma inhaler. Story

> A Sanofi ($SNY) official in India says it is looking for partners there to help it with drug development. Story

> The European Medicines Agency (EMA) will develop a list of drugs it believes need further R&D to test their appropriateness for use in children. Item 

> Indian drugmaker Aurobindo Pharma says it has gotten the nod from the FDA to launch a generic bioequivalent version of Novartis' Lotrel capsules for treating hypertension. Story

> Spectrum Pharmaceuticals said Thursday that it completed its acquisition of Allos Therapeutics, giving the combined company a third approved drug. Item

Biotech News

 @FierceBiotech: Respiratory virus tried as targeted cancer treatment. Story | Follow @FierceBiotech

 @JohnCFierce: Want to fix healthcare costs? IOM says there's $750B a year squandered in the U.S. Report | Follow @JohnCFierce

> Talent hunt spurs Sarepta's cross-country move to booming Boston hub. Story

> Safety threat forces AstraZeneca to scuttle obesity program. Report

> Promising PhIII apremilast data clear Celgene's path to the FDA. Article

> Pfizer partners on lung cancer drug in deal to speed Asian development. News

Medical Device News

 @FierceMedDev: Sony and Samsung are revving up their medtech rivalry. More | Follow @FierceMedDev

 @MarkHFierce: Dx investment continues, this time at Charles River Laboratories. Release | Follow @MarkHFierce

 @DamianFierce: The FDA wants feedback on its four-point plan to improve post-market surveillance for medical devices. Story | Follow @DamianFierce

> New York devicemakers look to China for sales. Report

> Device tax opponent downgrades from 'repeal' to 'delay.' Item

And Finally... A new study found that workers comp patients that buy their drugs directly from their physicians often pay more than twice what they would at a pharmacy. Story

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.